CSS LLC’s Jasper Therapeutics JSPR Stock Holding History

CSS LLC’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5,483	Closed	-$549K	–	1001
2020 Q4	$549K	Buy	+5,483	New	+$546K	0.02%	441

Other funds holding JSPR

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

QUSVM

Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CSS LLC's JSPR Position: Q1 2021 in Review

CSS LLC sold out of Jasper Therapeutics (JSPR) in Q1 2021, closing a stake of 5,483 shares — an estimated $549K sold.

CSS LLC first reported a position in JSPR in Q4 2020 and held it in 1 quarter. The position peaked at $549K in Q4 2020. 53 funds tracked by Wall St. Rank hold JSPR as of Q1 2021.

CSS LLC reported no remaining Jasper Therapeutics position as of Q1 2021 after selling out during the quarter.
CSS LLC sold 5,483 Jasper Therapeutics shares in Q1 2021, an estimated $549K.
CSS LLC first reported a position in Jasper Therapeutics in Q4 2020 and held it in 1 quarter.
CSS LLC's Jasper Therapeutics position peaked at $549K in Q4 2020.
53 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2021.

Based on CSS LLC's 13F filing for Q1 2021, filed 17 May 2021.